Company Overview and News

 
Telus: Long-Term Wealth Generating Stock

2018-09-19 seekingalpha
Editor's note: Seeking Alpha is proud to welcome Sapient Investor as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more »
SJR.B CMCSA SJR SJRWF TU SJR.A

11
6 Monthly Dividend Stocks to Buy

2018-09-14 investorplace - 1
Most dividend stocks pay their shareholders quarterly, but a few dividend yielding stocks offer monthly distributions.
SJR.B WBA LTC SJRWF OPRF SJR.A KMI PAA KMR STAG CVB APLE O SJR FDX MAR HLT PBA KMRFZ

 
Shaw Communications Inc. Fourth Quarter Fiscal 2018 Conference Call

2018-09-12 globenewswire
CALGARY, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Shaw Communications Inc. (“Shaw”) will be releasing its consolidated results for the Fourth Quarter (ending August 31, 2018) the morning of Thursday, October 25, 2018.
SJR.B WIREX SJR SJRWF SJR.A

1
Shaw Provides Dividend Rate Notice for Cumulative Redeemable Floating Rate Class 2 Preferred Shares, Series B

2018-08-31 globenewswire - 1
CALGARY, Alberta, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Shaw Communications Inc. (“Shaw”) announced today that it has given the registered shareholders of its Cumulative Redeemable Floating Rate Class 2 Preferred Shares, Series B (the “Series B Shares”) notice of dividend rates.
SJR.B WIREX SJR SJRWF SJR.A

 
SugarBud Craft Growers Corp. Provides Update Regarding Management Changes and Additions, Funding of Cannabis Operations, Insider Participation in Rights Offering, Investment in Inner Spirit Holdings Ltd. and Announces Option Grant

2018-08-10 globenewswire
CALGARY, Alberta, Aug. 09, 2018 (GLOBE NEWSWIRE) -- SugarBud Craft Growers Corp. (“SugarBud” or the “Company”) is pleased to announce that it has appointed Mr. Craig Kolochuk, SugarBud’s President, to the position of President and Chief Executive Officer, Mr. Sander Steer to the position of Vice President, Growing Operations, Infrastructure and Technology and Mr. Corey Scott to the position of Master Cultivator.
CJ SJR.B CRLFF SJR SJRWF SJR.A

 
PRESS DIGEST - Canada - Aug 8

2018-08-08 reuters
Aug 8 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
BCE RCIAF RCI SJR.B KML SJR SJRWF MAXR SJR.A

 
BCE: Investors Should Look Beyond Its Near-Term Weakness

2018-08-07 seekingalpha
Investors of BCE should look beyond its near-term weakness and look forward to the opportunities in the era of 5G.
RCIAF RCI SJR.B SJR BCE SJRWF QBCRF SJR.A

 
Bell subscriber base grows, but BCE Q2 misses estimates

2018-08-02 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
BCE RCIAF RCI SJR.B BCEXF SJR SJRWF SJR.A

 
You Deserve More Data. You Deserve Freedom: Will Arnett Sends Canadians a Message in New Freedom Mobile Ad Campaign

2018-08-01 globenewswire
CALGARY, Alberta, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Freedom Mobile today unveiled a bold new advertising campaign that highlights the expensive pain points that consumers often experience with their wireless service and shows Canadians that they can get more value through Freedom Mobile.
SJR.B WIREX SJR SJRWF SJR.A

 
More Canadians Get Fairer Pricing With New Plans From Freedom Mobile

2018-07-19 globenewswire
CALGARY, Alberta, July 19, 2018 (GLOBE NEWSWIRE) -- New wireless service plans announced today by Shaw Communications’ Freedom Mobile give Canadians more affordability and greater transparency into the services they are paying for from their mobile provider.
SJR.B SJR WIREX SJRWF SJR.A

 
Rogers beats profit estimates as wireless adds more users - Channel NewsAsia

2018-07-19 channelnewsasia
Rogers Communications Inc topped analysts' estimates for quarterly profit on Thursday, as more subscribers signed up for the Canadian telecom company's wireless postpaid services.
BCE RCIAF RCI SJR.B SJR SJRWF TU SJR.A

 
Is Cogeco Communications' Decelerating Internet Customers Growth A Concern?

2018-07-19 seekingalpha
Entry into wireless service appears to be a good strategy to defend its broadband Internet market share as it allows Cogeco to bundle its services.
RCIAF RCI SJR.B CCA SJR SJRWF CGEAF TU QBCRF SJR.A

 
Rogers faces earnings test in crowded Canadian wireless market

2018-07-18 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
BCE RCIAF RCI SJR.B BCEXF SJR SJRWF TU SJR.A

7
Rogers Communications (RCI) Q2 Earnings: What's in the Cards?

2018-07-16 zacks
Rogers Communications Inc. (RCI - Free Report) is set to release second-quarter 2018 results on Jul 19. The company beat the Zacks Consensus Estimate in the trailing four quarters, with an average positive surprise of 6.64%. In first-quarter 2018, earnings of 71 cents per share outpaced the Zacks Consensus Estimate of 60 cents. Total revenues of $2.88 billion also surpassed the Zacks Consensus Estimate of $2.
BCE NOC RCIAF RCI SJR.B TWTR SJR NFLX SJRWF SJR.A

 
Shaw Makes Streaming, Surfing and Gaming Better Than Ever With the Launch of Internet 300

2018-07-10 globenewswire
Virtually all Shaw customers across Western Canada can now enjoy Shaw’s fastest speeds on even more devices in the home at once
SJR.B SJR WIREX SJRWF SJR.A

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...